1. Home
  2. VSTS vs SUPN Comparison

VSTS vs SUPN Comparison

Compare VSTS & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTS
  • SUPN
  • Stock Information
  • Founded
  • VSTS 1936
  • SUPN 2005
  • Country
  • VSTS United States
  • SUPN United States
  • Employees
  • VSTS N/A
  • SUPN N/A
  • Industry
  • VSTS
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTS
  • SUPN Health Care
  • Exchange
  • VSTS Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • VSTS 2.2B
  • SUPN 1.9B
  • IPO Year
  • VSTS N/A
  • SUPN 2012
  • Fundamental
  • Price
  • VSTS $15.32
  • SUPN $36.43
  • Analyst Decision
  • VSTS Hold
  • SUPN Hold
  • Analyst Count
  • VSTS 6
  • SUPN 1
  • Target Price
  • VSTS $15.73
  • SUPN $36.00
  • AVG Volume (30 Days)
  • VSTS 2.6M
  • SUPN 348.4K
  • Earning Date
  • VSTS 02-05-2025
  • SUPN 02-25-2025
  • Dividend Yield
  • VSTS 0.92%
  • SUPN N/A
  • EPS Growth
  • VSTS N/A
  • SUPN 130.79
  • EPS
  • VSTS 0.16
  • SUPN 1.07
  • Revenue
  • VSTS $2,805,820,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • VSTS $2.82
  • SUPN $7.82
  • Revenue Next Year
  • VSTS $2.98
  • SUPN N/A
  • P/E Ratio
  • VSTS $95.51
  • SUPN $34.05
  • Revenue Growth
  • VSTS N/A
  • SUPN 6.79
  • 52 Week Low
  • VSTS $8.92
  • SUPN $25.53
  • 52 Week High
  • VSTS $22.37
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • VSTS 44.70
  • SUPN 52.26
  • Support Level
  • VSTS $14.96
  • SUPN $35.73
  • Resistance Level
  • VSTS $15.43
  • SUPN $37.34
  • Average True Range (ATR)
  • VSTS 0.43
  • SUPN 1.20
  • MACD
  • VSTS -0.16
  • SUPN -0.01
  • Stochastic Oscillator
  • VSTS 21.05
  • SUPN 69.02

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: